Global Generic Drug Intermediates CDMO Services Supply, Demand and Key Producers, 2023-2029
The global Generic Drug Intermediates CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to their cost-effectiveness and increasing focus on accessible healthcare. Generic drug manufacturers often seek specialized services from CDMOs for efficient and streamlined processes in the development and manufacturing of drug intermediates. CDMOs offer expertise, regulatory compliance, and cost-effective manufacturing solutions. As the pharmaceutical industry strives to meet the growing demand for generic drugs, the market for Generic Drug Intermediates CDMO Services is projected to expand, providing pharmaceutical companies with essential support to deliver high-quality and affordable medications.
Generic Drug Intermediates CDMO (Contract Development and Manufacturing Organization) Services refer to the outsourcing of research, development, and manufacturing processes related to the production of generic drug intermediates. CDMOs specialize in providing comprehensive services such as process development, optimization, scale-up, and commercial manufacturing of intermediates for generic drugs. These services include synthesis of key chemical compounds and intermediates that are essential in the production of generic pharmaceutical products. Generic Drug Intermediates CDMO Services offer pharmaceutical companies a cost-effective and efficient solution for the development and manufacturing of generic drugs, helping them meet regulatory requirements and bring quality, affordable medications to the market.
This report studies the global Generic Drug Intermediates CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Generic Drug Intermediates CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Drug Intermediates CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Generic Drug Intermediates CDMO Services total market, 2018-2029, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Generic Drug Intermediates CDMO Services total market, key domestic companies and share, (USD Million)
Global Generic Drug Intermediates CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Generic Drug Intermediates CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Euroapi, Cambrex, Recipharm, Thermo Fisher Scientific, Wuxi New Drug Development, Pharmaron Beijing, Asymchem Laboratories, Porton Pharma Solutions and ChengDa Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Generic Drug Intermediates CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Generic Drug Intermediates CDMO Services Market, By Region:
1. How big is the global Generic Drug Intermediates CDMO Services market?
2. What is the demand of the global Generic Drug Intermediates CDMO Services market?
3. What is the year over year growth of the global Generic Drug Intermediates CDMO Services market?
4. What is the total value of the global Generic Drug Intermediates CDMO Services market?
5. Who are the major players in the global Generic Drug Intermediates CDMO Services market?
6. What are the growth factors driving the market demand?
The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to their cost-effectiveness and increasing focus on accessible healthcare. Generic drug manufacturers often seek specialized services from CDMOs for efficient and streamlined processes in the development and manufacturing of drug intermediates. CDMOs offer expertise, regulatory compliance, and cost-effective manufacturing solutions. As the pharmaceutical industry strives to meet the growing demand for generic drugs, the market for Generic Drug Intermediates CDMO Services is projected to expand, providing pharmaceutical companies with essential support to deliver high-quality and affordable medications.
Generic Drug Intermediates CDMO (Contract Development and Manufacturing Organization) Services refer to the outsourcing of research, development, and manufacturing processes related to the production of generic drug intermediates. CDMOs specialize in providing comprehensive services such as process development, optimization, scale-up, and commercial manufacturing of intermediates for generic drugs. These services include synthesis of key chemical compounds and intermediates that are essential in the production of generic pharmaceutical products. Generic Drug Intermediates CDMO Services offer pharmaceutical companies a cost-effective and efficient solution for the development and manufacturing of generic drugs, helping them meet regulatory requirements and bring quality, affordable medications to the market.
This report studies the global Generic Drug Intermediates CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Generic Drug Intermediates CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Drug Intermediates CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Generic Drug Intermediates CDMO Services total market, 2018-2029, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Generic Drug Intermediates CDMO Services total market, key domestic companies and share, (USD Million)
Global Generic Drug Intermediates CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Generic Drug Intermediates CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Generic Drug Intermediates CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Euroapi, Cambrex, Recipharm, Thermo Fisher Scientific, Wuxi New Drug Development, Pharmaron Beijing, Asymchem Laboratories, Porton Pharma Solutions and ChengDa Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Generic Drug Intermediates CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Generic Drug Intermediates CDMO Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Process Optimization of Generic Intermediates
- Production of Generic Intermediates
- Pharmaceutical Enterprise
- Laboratory
- Other
- Euroapi
- Cambrex
- Recipharm
- Thermo Fisher Scientific
- Wuxi New Drug Development
- Pharmaron Beijing
- Asymchem Laboratories
- Porton Pharma Solutions
- ChengDa Pharmaceuticals
1. How big is the global Generic Drug Intermediates CDMO Services market?
2. What is the demand of the global Generic Drug Intermediates CDMO Services market?
3. What is the year over year growth of the global Generic Drug Intermediates CDMO Services market?
4. What is the total value of the global Generic Drug Intermediates CDMO Services market?
5. Who are the major players in the global Generic Drug Intermediates CDMO Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Generic Drug Intermediates CDMO Services Introduction
1.2 World Generic Drug Intermediates CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Generic Drug Intermediates CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Generic Drug Intermediates CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.3 China Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.4 Europe Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.5 Japan Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.6 South Korea Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.8 India Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Generic Drug Intermediates CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Generic Drug Intermediates CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.2 World Generic Drug Intermediates CDMO Services Consumption Value by Region
2.2.1 World Generic Drug Intermediates CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Generic Drug Intermediates CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.4 China Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.5 Europe Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.6 Japan Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.7 South Korea Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.9 India Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
3 WORLD GENERIC DRUG INTERMEDIATES CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Generic Drug Intermediates CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Generic Drug Intermediates CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Generic Drug Intermediates CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Generic Drug Intermediates CDMO Services in 2022
3.3 Generic Drug Intermediates CDMO Services Company Evaluation Quadrant
3.4 Generic Drug Intermediates CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Generic Drug Intermediates CDMO Services Market: Region Footprint
3.4.2 Generic Drug Intermediates CDMO Services Market: Company Product Type Footprint
3.4.3 Generic Drug Intermediates CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Generic Drug Intermediates CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Generic Drug Intermediates CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Generic Drug Intermediates CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Generic Drug Intermediates CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Generic Drug Intermediates CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Generic Drug Intermediates CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Generic Drug Intermediates CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Generic Drug Intermediates CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Generic Drug Intermediates CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Process Optimization of Generic Intermediates
5.2.2 Production of Generic Intermediates
5.3 Market Segment by Type
5.3.1 World Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
5.3.2 World Generic Drug Intermediates CDMO Services Market Size by Type (2024-2029)
5.3.3 World Generic Drug Intermediates CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Generic Drug Intermediates CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Enterprise
6.2.2 Laboratory
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
6.3.2 World Generic Drug Intermediates CDMO Services Market Size by Application (2024-2029)
6.3.3 World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Euroapi
7.1.1 Euroapi Details
7.1.2 Euroapi Major Business
7.1.3 Euroapi Generic Drug Intermediates CDMO Services Product and Services
7.1.4 Euroapi Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Euroapi Recent Developments/Updates
7.1.6 Euroapi Competitive Strengths & Weaknesses
7.2 Cambrex
7.2.1 Cambrex Details
7.2.2 Cambrex Major Business
7.2.3 Cambrex Generic Drug Intermediates CDMO Services Product and Services
7.2.4 Cambrex Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Cambrex Recent Developments/Updates
7.2.6 Cambrex Competitive Strengths & Weaknesses
7.3 Recipharm
7.3.1 Recipharm Details
7.3.2 Recipharm Major Business
7.3.3 Recipharm Generic Drug Intermediates CDMO Services Product and Services
7.3.4 Recipharm Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Recipharm Recent Developments/Updates
7.3.6 Recipharm Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product and Services
7.4.4 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Wuxi New Drug Development
7.5.1 Wuxi New Drug Development Details
7.5.2 Wuxi New Drug Development Major Business
7.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product and Services
7.5.4 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Wuxi New Drug Development Recent Developments/Updates
7.5.6 Wuxi New Drug Development Competitive Strengths & Weaknesses
7.6 Pharmaron Beijing
7.6.1 Pharmaron Beijing Details
7.6.2 Pharmaron Beijing Major Business
7.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Product and Services
7.6.4 Pharmaron Beijing Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pharmaron Beijing Recent Developments/Updates
7.6.6 Pharmaron Beijing Competitive Strengths & Weaknesses
7.7 Asymchem Laboratories
7.7.1 Asymchem Laboratories Details
7.7.2 Asymchem Laboratories Major Business
7.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Product and Services
7.7.4 Asymchem Laboratories Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Asymchem Laboratories Recent Developments/Updates
7.7.6 Asymchem Laboratories Competitive Strengths & Weaknesses
7.8 Porton Pharma Solutions
7.8.1 Porton Pharma Solutions Details
7.8.2 Porton Pharma Solutions Major Business
7.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product and Services
7.8.4 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Porton Pharma Solutions Recent Developments/Updates
7.8.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
7.9 ChengDa Pharmaceuticals
7.9.1 ChengDa Pharmaceuticals Details
7.9.2 ChengDa Pharmaceuticals Major Business
7.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product and Services
7.9.4 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ChengDa Pharmaceuticals Recent Developments/Updates
7.9.6 ChengDa Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Generic Drug Intermediates CDMO Services Industry Chain
8.2 Generic Drug Intermediates CDMO Services Upstream Analysis
8.3 Generic Drug Intermediates CDMO Services Midstream Analysis
8.4 Generic Drug Intermediates CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Generic Drug Intermediates CDMO Services Introduction
1.2 World Generic Drug Intermediates CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Generic Drug Intermediates CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Generic Drug Intermediates CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.3 China Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.4 Europe Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.5 Japan Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.6 South Korea Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.3.8 India Generic Drug Intermediates CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Generic Drug Intermediates CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Generic Drug Intermediates CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.2 World Generic Drug Intermediates CDMO Services Consumption Value by Region
2.2.1 World Generic Drug Intermediates CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Generic Drug Intermediates CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.4 China Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.5 Europe Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.6 Japan Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.7 South Korea Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
2.9 India Generic Drug Intermediates CDMO Services Consumption Value (2018-2029)
3 WORLD GENERIC DRUG INTERMEDIATES CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Generic Drug Intermediates CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Generic Drug Intermediates CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Generic Drug Intermediates CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Generic Drug Intermediates CDMO Services in 2022
3.3 Generic Drug Intermediates CDMO Services Company Evaluation Quadrant
3.4 Generic Drug Intermediates CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Generic Drug Intermediates CDMO Services Market: Region Footprint
3.4.2 Generic Drug Intermediates CDMO Services Market: Company Product Type Footprint
3.4.3 Generic Drug Intermediates CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Generic Drug Intermediates CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Generic Drug Intermediates CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Generic Drug Intermediates CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Generic Drug Intermediates CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Generic Drug Intermediates CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Generic Drug Intermediates CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Generic Drug Intermediates CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Generic Drug Intermediates CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Generic Drug Intermediates CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Process Optimization of Generic Intermediates
5.2.2 Production of Generic Intermediates
5.3 Market Segment by Type
5.3.1 World Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
5.3.2 World Generic Drug Intermediates CDMO Services Market Size by Type (2024-2029)
5.3.3 World Generic Drug Intermediates CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Generic Drug Intermediates CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Enterprise
6.2.2 Laboratory
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
6.3.2 World Generic Drug Intermediates CDMO Services Market Size by Application (2024-2029)
6.3.3 World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Euroapi
7.1.1 Euroapi Details
7.1.2 Euroapi Major Business
7.1.3 Euroapi Generic Drug Intermediates CDMO Services Product and Services
7.1.4 Euroapi Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Euroapi Recent Developments/Updates
7.1.6 Euroapi Competitive Strengths & Weaknesses
7.2 Cambrex
7.2.1 Cambrex Details
7.2.2 Cambrex Major Business
7.2.3 Cambrex Generic Drug Intermediates CDMO Services Product and Services
7.2.4 Cambrex Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Cambrex Recent Developments/Updates
7.2.6 Cambrex Competitive Strengths & Weaknesses
7.3 Recipharm
7.3.1 Recipharm Details
7.3.2 Recipharm Major Business
7.3.3 Recipharm Generic Drug Intermediates CDMO Services Product and Services
7.3.4 Recipharm Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Recipharm Recent Developments/Updates
7.3.6 Recipharm Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product and Services
7.4.4 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Wuxi New Drug Development
7.5.1 Wuxi New Drug Development Details
7.5.2 Wuxi New Drug Development Major Business
7.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product and Services
7.5.4 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Wuxi New Drug Development Recent Developments/Updates
7.5.6 Wuxi New Drug Development Competitive Strengths & Weaknesses
7.6 Pharmaron Beijing
7.6.1 Pharmaron Beijing Details
7.6.2 Pharmaron Beijing Major Business
7.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Product and Services
7.6.4 Pharmaron Beijing Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pharmaron Beijing Recent Developments/Updates
7.6.6 Pharmaron Beijing Competitive Strengths & Weaknesses
7.7 Asymchem Laboratories
7.7.1 Asymchem Laboratories Details
7.7.2 Asymchem Laboratories Major Business
7.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Product and Services
7.7.4 Asymchem Laboratories Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Asymchem Laboratories Recent Developments/Updates
7.7.6 Asymchem Laboratories Competitive Strengths & Weaknesses
7.8 Porton Pharma Solutions
7.8.1 Porton Pharma Solutions Details
7.8.2 Porton Pharma Solutions Major Business
7.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product and Services
7.8.4 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Porton Pharma Solutions Recent Developments/Updates
7.8.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
7.9 ChengDa Pharmaceuticals
7.9.1 ChengDa Pharmaceuticals Details
7.9.2 ChengDa Pharmaceuticals Major Business
7.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product and Services
7.9.4 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ChengDa Pharmaceuticals Recent Developments/Updates
7.9.6 ChengDa Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Generic Drug Intermediates CDMO Services Industry Chain
8.2 Generic Drug Intermediates CDMO Services Upstream Analysis
8.3 Generic Drug Intermediates CDMO Services Midstream Analysis
8.4 Generic Drug Intermediates CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Generic Drug Intermediates CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Generic Drug Intermediates CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Generic Drug Intermediates CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Generic Drug Intermediates CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Generic Drug Intermediates CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Generic Drug Intermediates CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Generic Drug Intermediates CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Generic Drug Intermediates CDMO Services Players in 2022
Table 12. World Generic Drug Intermediates CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Generic Drug Intermediates CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Generic Drug Intermediates CDMO Services Player
Table 15. Generic Drug Intermediates CDMO Services Market: Company Product Type Footprint
Table 16. Generic Drug Intermediates CDMO Services Market: Company Product Application Footprint
Table 17. Generic Drug Intermediates CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Generic Drug Intermediates CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Generic Drug Intermediates CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Generic Drug Intermediates CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 29. World Generic Drug Intermediates CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Generic Drug Intermediates CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Generic Drug Intermediates CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Generic Drug Intermediates CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Euroapi Basic Information, Area Served and Competitors
Table 36. Euroapi Major Business
Table 37. Euroapi Generic Drug Intermediates CDMO Services Product and Services
Table 38. Euroapi Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Euroapi Recent Developments/Updates
Table 40. Euroapi Competitive Strengths & Weaknesses
Table 41. Cambrex Basic Information, Area Served and Competitors
Table 42. Cambrex Major Business
Table 43. Cambrex Generic Drug Intermediates CDMO Services Product and Services
Table 44. Cambrex Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Cambrex Recent Developments/Updates
Table 46. Cambrex Competitive Strengths & Weaknesses
Table 47. Recipharm Basic Information, Area Served and Competitors
Table 48. Recipharm Major Business
Table 49. Recipharm Generic Drug Intermediates CDMO Services Product and Services
Table 50. Recipharm Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Recipharm Recent Developments/Updates
Table 52. Recipharm Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product and Services
Table 56. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Wuxi New Drug Development Basic Information, Area Served and Competitors
Table 60. Wuxi New Drug Development Major Business
Table 61. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product and Services
Table 62. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Wuxi New Drug Development Recent Developments/Updates
Table 64. Wuxi New Drug Development Competitive Strengths & Weaknesses
Table 65. Pharmaron Beijing Basic Information, Area Served and Competitors
Table 66. Pharmaron Beijing Major Business
Table 67. Pharmaron Beijing Generic Drug Intermediates CDMO Services Product and Services
Table 68. Pharmaron Beijing Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pharmaron Beijing Recent Developments/Updates
Table 70. Pharmaron Beijing Competitive Strengths & Weaknesses
Table 71. Asymchem Laboratories Basic Information, Area Served and Competitors
Table 72. Asymchem Laboratories Major Business
Table 73. Asymchem Laboratories Generic Drug Intermediates CDMO Services Product and Services
Table 74. Asymchem Laboratories Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Asymchem Laboratories Recent Developments/Updates
Table 76. Asymchem Laboratories Competitive Strengths & Weaknesses
Table 77. Porton Pharma Solutions Basic Information, Area Served and Competitors
Table 78. Porton Pharma Solutions Major Business
Table 79. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product and Services
Table 80. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Porton Pharma Solutions Recent Developments/Updates
Table 82. ChengDa Pharmaceuticals Basic Information, Area Served and Competitors
Table 83. ChengDa Pharmaceuticals Major Business
Table 84. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product and Services
Table 85. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Generic Drug Intermediates CDMO Services Upstream (Raw Materials)
Table 87. Generic Drug Intermediates CDMO Services Typical Customers
List of Figure
Figure 1. Generic Drug Intermediates CDMO Services Picture
Figure 2. World Generic Drug Intermediates CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Generic Drug Intermediates CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Generic Drug Intermediates CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Generic Drug Intermediates CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Generic Drug Intermediates CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Generic Drug Intermediates CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Generic Drug Intermediates CDMO Services Markets in 2022
Figure 27. United States VS China: Generic Drug Intermediates CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Generic Drug Intermediates CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Generic Drug Intermediates CDMO Services Market Size Market Share by Type in 2022
Figure 31. Process Optimization of Generic Intermediates
Figure 32. Production of Generic Intermediates
Figure 33. World Generic Drug Intermediates CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Generic Drug Intermediates CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Generic Drug Intermediates CDMO Services Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Enterprise
Figure 37. Laboratory
Figure 38. Other
Figure 39. Generic Drug Intermediates CDMO Services Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Generic Drug Intermediates CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Generic Drug Intermediates CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Generic Drug Intermediates CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Generic Drug Intermediates CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Generic Drug Intermediates CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Generic Drug Intermediates CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Generic Drug Intermediates CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Generic Drug Intermediates CDMO Services Players in 2022
Table 12. World Generic Drug Intermediates CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Generic Drug Intermediates CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Generic Drug Intermediates CDMO Services Player
Table 15. Generic Drug Intermediates CDMO Services Market: Company Product Type Footprint
Table 16. Generic Drug Intermediates CDMO Services Market: Company Product Application Footprint
Table 17. Generic Drug Intermediates CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Generic Drug Intermediates CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Generic Drug Intermediates CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Generic Drug Intermediates CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Generic Drug Intermediates CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Generic Drug Intermediates CDMO Services Revenue Market Share (2018-2023)
Table 29. World Generic Drug Intermediates CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Generic Drug Intermediates CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Generic Drug Intermediates CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Generic Drug Intermediates CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Euroapi Basic Information, Area Served and Competitors
Table 36. Euroapi Major Business
Table 37. Euroapi Generic Drug Intermediates CDMO Services Product and Services
Table 38. Euroapi Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Euroapi Recent Developments/Updates
Table 40. Euroapi Competitive Strengths & Weaknesses
Table 41. Cambrex Basic Information, Area Served and Competitors
Table 42. Cambrex Major Business
Table 43. Cambrex Generic Drug Intermediates CDMO Services Product and Services
Table 44. Cambrex Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Cambrex Recent Developments/Updates
Table 46. Cambrex Competitive Strengths & Weaknesses
Table 47. Recipharm Basic Information, Area Served and Competitors
Table 48. Recipharm Major Business
Table 49. Recipharm Generic Drug Intermediates CDMO Services Product and Services
Table 50. Recipharm Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Recipharm Recent Developments/Updates
Table 52. Recipharm Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product and Services
Table 56. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Wuxi New Drug Development Basic Information, Area Served and Competitors
Table 60. Wuxi New Drug Development Major Business
Table 61. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product and Services
Table 62. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Wuxi New Drug Development Recent Developments/Updates
Table 64. Wuxi New Drug Development Competitive Strengths & Weaknesses
Table 65. Pharmaron Beijing Basic Information, Area Served and Competitors
Table 66. Pharmaron Beijing Major Business
Table 67. Pharmaron Beijing Generic Drug Intermediates CDMO Services Product and Services
Table 68. Pharmaron Beijing Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pharmaron Beijing Recent Developments/Updates
Table 70. Pharmaron Beijing Competitive Strengths & Weaknesses
Table 71. Asymchem Laboratories Basic Information, Area Served and Competitors
Table 72. Asymchem Laboratories Major Business
Table 73. Asymchem Laboratories Generic Drug Intermediates CDMO Services Product and Services
Table 74. Asymchem Laboratories Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Asymchem Laboratories Recent Developments/Updates
Table 76. Asymchem Laboratories Competitive Strengths & Weaknesses
Table 77. Porton Pharma Solutions Basic Information, Area Served and Competitors
Table 78. Porton Pharma Solutions Major Business
Table 79. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product and Services
Table 80. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Porton Pharma Solutions Recent Developments/Updates
Table 82. ChengDa Pharmaceuticals Basic Information, Area Served and Competitors
Table 83. ChengDa Pharmaceuticals Major Business
Table 84. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product and Services
Table 85. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Generic Drug Intermediates CDMO Services Upstream (Raw Materials)
Table 87. Generic Drug Intermediates CDMO Services Typical Customers
List of Figure
Figure 1. Generic Drug Intermediates CDMO Services Picture
Figure 2. World Generic Drug Intermediates CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Generic Drug Intermediates CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Generic Drug Intermediates CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Generic Drug Intermediates CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Generic Drug Intermediates CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Generic Drug Intermediates CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Generic Drug Intermediates CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Generic Drug Intermediates CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Generic Drug Intermediates CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Generic Drug Intermediates CDMO Services Markets in 2022
Figure 27. United States VS China: Generic Drug Intermediates CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Generic Drug Intermediates CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Generic Drug Intermediates CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Generic Drug Intermediates CDMO Services Market Size Market Share by Type in 2022
Figure 31. Process Optimization of Generic Intermediates
Figure 32. Production of Generic Intermediates
Figure 33. World Generic Drug Intermediates CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Generic Drug Intermediates CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Generic Drug Intermediates CDMO Services Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Enterprise
Figure 37. Laboratory
Figure 38. Other
Figure 39. Generic Drug Intermediates CDMO Services Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
